Lilly Stock Heading $1,000? What Investors Should Know
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Rebalancing can affect how withdrawal rates hold up over time. Learn factors that influence stability and how to adjust portfolio rules.
24,481 articlesInvestors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
The April consumer price index rose 0.6% from March, pushing annual inflation to 3.8%. Energy costs led the gain, wit...
Micron’s latest earnings and bold capex plans intensify the debate over whether the memory giant can achieve a trilli...
The United States faces a thinner fiscal buffer as debt climbs to $39 trillion, now taller than annual GDP. A top eco...
Nokia's CEO warns that companies using AI must rethink work processes as automation turns ideas into action faster, r...
XRP has pulled back from its highs, trading around $1.44 after a loss from a $3.65 peak. Three major catalysts could ...
Citi sees the recent aerospace pullback as a rare entry point for Boeing, lifting the target to $260 and signaling a ...
A Dallas-based brokerage joins Compass, expanding its footprint across Dallas–Fort Worth and Austin with a team of 10...
CWB blends income with potential equity upside, but its behavior shifts from bond-like to stock-like in market downtu...
SpaceX unveiled a century long strategy spanning launches, Starlink, and AI, pushing the company toward a potential $...
Housing costs are rising not only from prices but from the way homes are built and financed. This report explains how...
May data show rising inflation pressures even as growth slows, with renewed Middle East tensions fanning fears of sta...